Skip to main content

Table 1 Approaches used in the treatment of acute graft-versus-host disease following orthotopic liver transplantation

From: Acute graft versus host disease after orthotopic liver transplantation

Most common treatments Corticosteroids (most), calcineurin inhibitors (many), granulocyte colony stimulating factors (many)
Antimetabolites Azathioprine [30]
Alkylating agents Cyclophosphamide [24]
Anti-T cell antibodies Anti-thymocyte globulin [5, 19, 24, 3145]
  OKT3 [24, 42]
  Campath [38, 46, 47]
  Alefacept [43]
Anti-B cell antibodies Rituximab [46, 48]
Immunoglobulin Immunoglobulin [4, 49, 50]
Cytokine inhibitors Infliximab (TNF) [3, 31]
  Etanercept (TNF) [51]
  Daclizumab (IL2R) [3, 38, 41, 46, 5254]
  Basiliximab (IL2R) [5, 39, 44, 47, 48, 55, 56]
Immunostimulants Thymosin alpha 1 [4, 41]
Cellular therapy Ex vivo T cell expansion [47]
  Hematopoietic cell transplantation [24, 32, 34]